---
input_text: 'Exome Sequencing Identified a Splice Site Mutation in FHL1 that Causes
  Uruguay Syndrome, an X-Linked Disorder With Skeletal Muscle Hypertrophy and Premature
  Cardiac Death.BACKGROUND: Previously, we reported a rare X-linked disorder, Uruguay
  syndrome in a single family. The main features are pugilistic facies, skeletal deformities,
  and muscular hypertrophy despite a lack of exercise and cardiac ventricular hypertrophy
  leading to premature death. METHODS AND RESULTS: An  19 Mb critical region on X
  chromosome was identified through identity-by-descent analysis of 3 affected males.
  Exome sequencing was conducted on one affected male to identify the disease-causing
  gene and variant. A splice site variant (c.502-2A>G) in the FHL1 gene was highly
  suspicious among other candidate genes and variants. FHL1A is the predominant isoform
  of FHL1 in cardiac and skeletal muscle. Sequencing cDNA showed the splice site variant
  led to skipping of exons 6 of the FHL1A isoform, equivalent to the FHL1C isoform.
  Targeted analysis showed that this splice site variant cosegregated with disease
  in the family. Western blot and immunohistochemical analysis of muscle from the
  proband showed a significant decrease in protein expression of FHL1A. Real-time
  polymerase chain reaction analysis of different isoforms of FHL1 demonstrated that
  the FHL1C is markedly increased. CONCLUSIONS: Mutations in the FHL1 gene have been
  reported in disorders with skeletal and cardiac myopathy but none has the skeletal
  or facial phenotype seen in patients with Uruguay syndrome. Our data suggest that
  a novel FHL1 splice site variant results in the absence of FHL1A and the abundance
  of FHL1C, which may contribute to the complex and severe phenotype. Mutation screening
  of the FHL1 gene should be considered for patients with uncharacterized myopathies
  and cardiomyopathies.'
raw_completion_output: |-
  primary_disease: Uruguay Syndrome

  medical_actions: Exome sequencing; Identity-by-descent analysis; Sequencing cDNA; Targeted analysis; Western blot; Immunohistochemical analysis; Real-time polymerase chain reaction analysis; Mutation screening

  symptoms: Pugilistic facies; Skeletal deformities; Muscular hypertrophy; Cardiac ventricular hypertrophy; Premature cardiac death

  chemicals: 

  action_annotation_relationships: Exome sequencing TREATS identification of genetic mutation IN Uruguay Syndrome; Identity-by-descent analysis TREATS identification of genetic mutation IN Uruguay Syndrome; Sequencing cDNA TREATS identification of splice site variant IN Uruguay Syndrome; Targeted analysis TREATS verification of disease-causing variant IN Uruguay Syndrome; Mutation screening (of the FHL1 gene) TREATS uncharacterized myopathies and cardiomyopathies IN Uruguay Syndrome
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Mutation screening (of the FHL1 gene) TREATS uncharacterized myopathies and cardiomyopathies IN Uruguay Syndrome

  ===

extracted_object:
  primary_disease: Uruguay Syndrome
  medical_actions:
    - MAXO:0009004
    - Identity-by-descent analysis
    - Sequencing cDNA
    - Targeted analysis
    - Western blot
    - Immunohistochemical analysis
    - Real-time polymerase chain reaction analysis
    - Mutation screening
  symptoms:
    - HP:0000339
    - Skeletal deformities
    - HP:0003712
    - Cardiac ventricular hypertrophy
    - Premature cardiac death
  action_annotation_relationships:
    - subject: <Exome sequencing>
      predicate: <TREATS>
      object: <identification of genetic mutation>
      qualifier: <Uruguay Syndrome>
      subject_extension: <Exome sequencing>
    - subject: <Identity-by-descent analysis>
      predicate: <TREATS>
      object: <identification of genetic mutation>
      qualifier: <Uruguay Syndrome>
      subject_qualifier: <>
      object_qualifier: <>
      subject_extension: <Identity-by-descent analysis>
      object_extension: <genetic mutation>
    - subject: Sequencing
      predicate: TREATS
      object: identification
      qualifier: Uruguay Syndrome
      subject_extension: cDNA sequencing
      object_extension: splice site variant
    - subject: <Targeted analysis>
      predicate: <TREATS>
      object: <verification of disease-causing variant>
      qualifier: <Uruguay Syndrome>
      subject_extension: <Targeted analysis>
    - subject: <Mutation screening>
      predicate: <TREATS>
      object: <uncharacterized myopathies and cardiomyopathies>
      qualifier: <Uruguay Syndrome>
      subject_extension: <FHL1 gene>
named_entities:
  - id: MONDO:0008891
    label: Brown-Vialetto-Van Laere syndrome
  - id: MAXO:0009004
    label: exome sequencing
  - id: HP:0000407
    label: sensorineural hearing loss
  - id: HP:0002093
    label: respiratory insufficiency
  - id: HP:0010871
    label: sensory ataxia
  - id: HP:0000648
    label: optic atrophy
  - id: CHEBI:17015
    label: riboflavin
  - id: HP:0012469
    label: infantile spasms
  - id: HP:0000789
    label: infertility
  - id: HP:0005268
    label: miscarriage
  - id: CHEBI:16709
    label: pyridoxine
  - id: CHEBI:18405
    label: pyridoxal 5'-phosphate
  - id: CHEBI:27306
    label: vitamin B6
  - id: CHEBI:24041
    label: flavin mononucleotide
  - id: HP:0001250
    label: seizures
  - id: MONDO:0009974
    label: Familial hemophagocytic lymphohistiocytosis
  - id: MAXO:0010030
    label: bone marrow transplantation (BMT)
  - id: CHEBI:28901
    label: busulfan
  - id: CHEBI:4027
    label: cyclophosphamide
  - id: CHEBI:4911
    label: etoposide
  - id: MAXO:0000757
    label: infusion
  - id: CHEBI:41264
    label: busulfan (BU), cyclophosphamide (CP), etoposide (VP16), antithymocyte globulin
      (ATG)
  - id: MAXO:0000750
    label: conditioning regimen
  - id: CHEBI:73896
    label: gene therapy (GT)
  - id: MONDO:0009666
    label: Holocarboxylase synthetase deficiency
  - id: MAXO:0000603
    label: Peritoneal dialysis
  - id: HP:0001942
    label: Metabolic acidosis
  - id: CHEBI:15956
    label: Biotin
  - id: HP:0003256
    label: Coagulopathy
  - id: CHEBI:48669
    label: Tranexamic acid
  - id: CHEBI:48675
    label: antifibrinolytic agents
  - id: MONDO:0020300
    label: Autosomal dominant nocturnal frontal lobe epilepsy
  - id: CHEBI:3387
    label: Carbamazepine
  - id: MONDO:0000903
    label: Myoclonus-dystonia
  - id: MAXO:0000943
    label: Deep Brain Stimulation
  - id: HP:0001252
    label: Hypotonia
  - id: MONDO:0005338
    label: Primary open-angle glaucoma (POAG)
  - id: MAXO:0001082
    label: Trabeculectomy
  - id: MAXO:0000960
    label: Viscocanalostomy
  - id: HP:0007906
    label: Elevated intraocular pressure (IOP)
  - id: HP:0000253
    label: Progressive microcephaly
  - id: HP:0001263
    label: Global developmental delay
  - id: HP:0000365
    label: Hearing loss
  - id: HP:0100785
    label: Insomnia
  - id: CHEBI:15681
    label: GM3
  - id: CHEBI:28892
    label: Ganglioside
  - id: MAXO:0001298
    label: therapies
  - id: MAXO:0000950
    label: Supportive care
  - id: CHEBI:8378
    label: Prednisolone
  - id: MONDO:0015626
    label: Charcot-Marie-Tooth disease (CMT)
  - id: MAXO:0035087
    label: peripheral nerve biopsy
  - id: HP:0011096
    label: demyelination
  - id: HP:0001605
    label: vocal cord paralysis
  - id: MONDO:0007947
    label: Marfan's syndrome
  - id: HP:0001659
    label: aortic regurgitation
  - id: CHEBI:2904
    label: atenolol
  - id: CHEBI:6541
    label: losartan
  - id: MONDO:0004691
    label: Autosomal dominant polycystic kidney disease (ADPKD)
  - id: MAXO:0000004
    label: surgery
  - id: HP:0002586
    label: peritonitis
  - id: HP:0100543
    label: cognitive impairment
  - id: HP:0003546
    label: exercise intolerance
  - id: HP:0001332
    label: dystonia
  - id: HP:0001336
    label: myoclonus
  - id: HP:0001272
    label: cerebellar atrophy
  - id: HP:0002059
    label: cerebral atrophy
  - id: CHEBI:46245
    label: coenzyme Q10 (CoQ10)
  - id: MONDO:0009693
    label: multiple myeloma
  - id: HP:0002720
    label: IgA deficiency
  - id: HP:0006775
    label: multiple myeloma
  - id: MONDO:0011787
    label: Limb-girdle muscular dystrophy type 2I (LGMD2I)
  - id: MONDO:0009662
    label: Sly disease (mucopolysaccharidosis VII)
  - id: HP:0002321
    label: vertigo
  - id: HP:0040268
    label: recurrent infections of the middle ears
  - id: MONDO:0100137
    label: Telomere Diseases
  - id: HP:0005528
    label: Bone marrow failure
  - id: HP:0001394
    label: Liver cirrhosis
  - id: HP:0002206
    label: Pulmonary fibrosis
  - id: HP:0003394
    label: Muscle cramps
  - id: CHEBI:4315
    label: Danazol
  - id: MONDO:0015286
    label: complete DiGeorge syndrome (cDGS)
  - id: MAXO:0010042
    label: Thymus transplantation
  - id: HP:0001973
    label: Autoimmune thrombocytopenia
  - id: HP:0100646
    label: Thyroiditis
  - id: HP:0001875
    label: Neutropenia
  - id: HP:0012378
    label: fatigue
  - id: MONDO:0010421
    label: X-linked Agammaglobulinemia
  - id: MONDO:0005180
    label: Parkinson disease
  - id: MONDO:0007765
    label: Hyperostosis cranialis interna
  - id: MONDO:0018997
    label: Noonan syndrome
  - id: HP:0004322
    label: short stature
  - id: MONDO:0015168
    label: arthrogryposis multiplex congenita
  - id: HP:0002828
    label: multiple joint contractures
  - id: HP:0034392
    label: joint contractures
  - id: MONDO:0010518
    label: Wiskott-Aldrich syndrome (WAS)
  - id: MAXO:0001077
    label: splenectomy
  - id: HP:0001873
    label: thrombocytopenia
  - id: MONDO:0011724
    label: Glut-1 deficiency syndrome
  - id: HP:0005484
    label: acquired microcephaly
  - id: HP:0001257
    label: spasticity
  - id: HP:0001251
    label: ataxia
  - id: HP:0011972
    label: hypoglycorrhachia
  - id: MONDO:0000188
    label: GLUT1 deficiency syndrome
  - id: HP:0001508
    label: Failure to thrive
  - id: HP:0000787
    label: Renal stones
  - id: CHEBI:37054
    label: 3-hydroxybutyrate
  - id: MONDO:0019353
    label: Stargardt disease
  - id: MONDO:0015974
    label: Severe combined immunodeficiency (SCID)
  - id: HP:0000964
    label: eczema
  - id: HP:0002960
    label: autoimmunity
  - id: HP:0001892
    label: hemorrhagic diathesis
  - id: MAXO:0000756
    label: transfusion
  - id: MONDO:0009561
    label: alpha-mannosidosis
  - id: HP:0003812
    label: clinical heterogeneity
  - id: MONDO:0007374
    label: Sickle cell disease (SCD)
  - id: MAXO:0000011
    label: Physical therapy
  - id: MAXO:0000652
    label: Angiotensin-converting enzyme inhibitor therapy
  - id: MAXO:0010203
    label: Echocardiography
  - id: HP:0010885
    label: Avascular necrosis
  - id: HP:0012594
    label: Microalbuminuria
  - id: HP:0002092
    label: Pulmonary hypertension
  - id: CHEBI:44423
    label: Hydroxyurea
  - id: CHEBI:17334
    label: Penicillin
  - id: CHEBI:35457
    label: Angiotensin-converting enzyme inhibitors
  - id: HP:0001297
    label: stroke
  - id: CHEBI:35480
    label: analgesics
  - id: MONDO:0009061
    label: Cystic fibrosis
  - id: MONDO:0010926
    label: Familial Hypocalciuric Hypercalcemia type 3 (FHH3)
  - id: HP:0003072
    label: Hypercalcemia
  - id: HP:0002150
    label: Hypercalciuria
  - id: CHEBI:22984
    label: Calcium
  - id: MONDO:0018868
    label: Metachromatic leukodystrophy
  - id: MAXO:0010033
    label: Umbilical cord blood transplantation
  - id: MAXO:0035059
    label: Nerve conduction studies
  - id: CHEBI:71418
    label: Triamcinolone acetonide
  - id: MONDO:0009216
    label: Fanconi-Bickel syndrome
  - id: MAXO:0000780
    label: Growth hormone therapy
  - id: CHEBI:37845
    label: Growth hormone (GH)
  - id: MAXO:0000088
    label: Dietary intervention
  - id: HP:0200134
    label: Epileptic encephalopathy
  - id: CHEBI:16704
    label: Uridine
  - id: MONDO:0005041
    label: Glaucoma
  - id: HP:0000618
    label: blindness
  - id: MONDO:0019234
    label: Peroxisome biogenesis disorder
  - id: HP:0001260
    label: Dysarthric speech
  - id: HP:0000958
    label: Dry skin
  - id: HP:0001284
    label: Absent reflexes
  - id: HP:0001083
    label: ectopia lentis
  - id: MONDO:0010626
    label: X-linked hyper-IgM syndrome
  - id: MONDO:0018875
    label: Li-Fraumeni syndrome
  - id: MAXO:0000527
    label: physical examination
  - id: MAXO:0000427
    label: brain MRI
  - id: MAXO:0000431
    label: breast MRI
  - id: MAXO:0010363
    label: mammography
  - id: MAXO:0001184
    label: colonoscopy
  - id: MONDO:0021055
    label: Familial amyloid polyneuropathy (FAP)
  - id: MAXO:0001175
    label: liver transplantation
  - id: MONDO:0005154
    label: Liver disease
  - id: MAXO:0000376
    label: Liver biopsy
  - id: HP:0200084
    label: Neonatal hepatitis
  - id: CHEBI:16359
    label: Cholic acid
  - id: CHEBI:16285
    label: Phytanic acid
  - id: CHEBI:51340
    label: Pristanic acid
  - id: CHEBI:3098
    label: bile acid
  - id: MONDO:0042982
    label: GATA2 deficiency
  - id: MAXO:0000747
    label: nonmyeloablative hematopoietic stem cell transplantation (HSCT)
  - id: HP:0012312
    label: monocytopenia
  - id: HP:0000100
    label: nephrotic syndrome
  - id: CHEBI:61049
    label: tacrolimus
  - id: CHEBI:9168
    label: sirolimus
  - id: MONDO:0004737
    label: Homocystinuria
  - id: CHEBI:27470
    label: folic acid
  - id: MONDO:0010998
    label: ALG3-CDG
  - id: HP:0001510
    label: growth retardation
  - id: HP:0000252
    label: microcephaly
  - id: HP:0001028
    label: hemangioma
  - id: HP:0003774
    label: Chronic renal failure
  - id: CHEBI:30411
    label: cobalamin
  - id: CHEBI:27786
    label: hydroxocobalamin
  - id: HP:0000339
    label: Pugilistic facies
  - id: HP:0003712
    label: Muscular hypertrophy
